Aurea Biotech is now the uncommon U.S. distributor of ATTIVA, an evolved subdermal radiofrequency expertise. This transition strengthens Aurea Biotech’s commitment to providing excessive-quality, compliant, and innovative comely solutions. CEO Jack McCarthy emphasizes the corporate’s focal level on regulatory requirements, product integrity, and practitioner strengthen. Aurea Biotech looks to be like forward to persevering with its management in[PRcom[PRcom
Learn More
Aurea Biotech Announces U.S. Distribution of ATTIVA
You May Also Like
Posted in
Biotech
New from the biotech pipeline: FDA turmoil overshadows 2025 approvals
Posted by
News Author
Posted in
Biotech
Danish biotech Cellugy needs to replace microplastics in cosmetics
Posted by
News Author
More From Author
Posted in
Main
This HP EliteBook notebook computer with 16GB of RAM is nice $245
Posted by
News Author
Sonos has reportedly dropped surely one of its worst tips